Nalpropion Pharmaceuticals, Inc. Morristown, NJ 07960Asset Purchase Agreement • July 31st, 2018 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations
Reference is made to the Asset Purchase Agreement dated as of April 23, 2018 (as may be amended from time to time, the “Agreement”) by and between Orexigen Therapeutics, Inc., a Delaware corporation and Nalpropion Pharmaceuticals, Inc., a Delaware corporation. Capitalized terms used herein without definition herein have the respective meanings set forth in the Agreement.
